chr2-171791578-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_003705.5(SLC25A12):​c.1458G>A​(p.Ala486Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00466 in 1,613,902 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0039 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0047 ( 25 hom. )

Consequence

SLC25A12
NM_003705.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.0250

Publications

1 publications found
Variant links:
Genes affected
SLC25A12 (HGNC:10982): (solute carrier family 25 member 12) This gene encodes a calcium-binding mitochondrial carrier protein. The encoded protein localizes to the mitochondria and is involved in the exchange of aspartate for glutamate across the inner mitochondrial membrane. Polymorphisms in this gene may be associated with autism, and mutations in this gene may also be a cause of global cerebral hypomyelination. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Apr 2012]
SLC25A12 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 39
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • mitochondrial disease
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.26).
BP6
Variant 2-171791578-C-T is Benign according to our data. Variant chr2-171791578-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 332338.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.025 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00391 (595/152204) while in subpopulation NFE AF = 0.00576 (392/68010). AF 95% confidence interval is 0.00529. There are 2 homozygotes in GnomAd4. There are 304 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC25A12NM_003705.5 linkc.1458G>A p.Ala486Ala synonymous_variant Exon 15 of 18 ENST00000422440.7 NP_003696.2
SLC25A12XM_047446142.1 linkc.1185G>A p.Ala395Ala synonymous_variant Exon 13 of 16 XP_047302098.1
SLC25A12NR_047549.2 linkn.1372G>A non_coding_transcript_exon_variant Exon 14 of 17

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC25A12ENST00000422440.7 linkc.1458G>A p.Ala486Ala synonymous_variant Exon 15 of 18 1 NM_003705.5 ENSP00000388658.2
SLC25A12ENST00000263812.8 linkn.*1078G>A non_coding_transcript_exon_variant Exon 14 of 17 2 ENSP00000263812.4
SLC25A12ENST00000263812.8 linkn.*1078G>A 3_prime_UTR_variant Exon 14 of 17 2 ENSP00000263812.4

Frequencies

GnomAD3 genomes
AF:
0.00391
AC:
595
AN:
152086
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000942
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00288
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.00943
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00576
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00357
AC:
898
AN:
251458
AF XY:
0.00368
show subpopulations
Gnomad AFR exome
AF:
0.000923
Gnomad AMR exome
AF:
0.00150
Gnomad ASJ exome
AF:
0.00139
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00993
Gnomad NFE exome
AF:
0.00448
Gnomad OTH exome
AF:
0.00293
GnomAD4 exome
AF:
0.00473
AC:
6921
AN:
1461698
Hom.:
25
Cov.:
31
AF XY:
0.00464
AC XY:
3375
AN XY:
727166
show subpopulations
African (AFR)
AF:
0.000896
AC:
30
AN:
33476
American (AMR)
AF:
0.00143
AC:
64
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
30
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39692
South Asian (SAS)
AF:
0.00265
AC:
229
AN:
86254
European-Finnish (FIN)
AF:
0.00945
AC:
505
AN:
53418
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5766
European-Non Finnish (NFE)
AF:
0.00520
AC:
5783
AN:
1111840
Other (OTH)
AF:
0.00450
AC:
272
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
349
698
1046
1395
1744
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
200
400
600
800
1000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00391
AC:
595
AN:
152204
Hom.:
2
Cov.:
32
AF XY:
0.00409
AC XY:
304
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.000939
AC:
39
AN:
41532
American (AMR)
AF:
0.00288
AC:
44
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.000865
AC:
3
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00208
AC:
10
AN:
4818
European-Finnish (FIN)
AF:
0.00943
AC:
100
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00576
AC:
392
AN:
68010
Other (OTH)
AF:
0.00332
AC:
7
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
30
60
90
120
150
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00424
Hom.:
2
Bravo
AF:
0.00280
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00551
EpiControl
AF:
0.00314

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Sep 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SLC25A12: BP4, BP7, BS2

Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SLC25A12-related disorder Benign:1
May 01, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.26
CADD
Benign
10
DANN
Benign
0.58
PhyloP100
0.025
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142179562; hg19: chr2-172648088; COSMIC: COSV99785628; COSMIC: COSV99785628; API